A comprehensive understanding of the pathways related to MCRS1 will aid in evaluating the potential of MCRS1 or MCRS1-targeting agents as candidate drugs for inhibiting tumor growth and improving patient survival. The gene discussed is MCRS1; the disease is neoplasm.